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Abstract
Objectives: Guidelines to treat acute otitis media (AOM) were published in 2004. Initial declines in prescribing were shown,
but it’s unknown if they were sustained. We examine trends in antibiotic dispensing patterns to treat AOM among a large
population of children. We also document trends in antibiotic failure.
Study Design: Children aged 3 months to 12 years with an AOM diagnosis, enrolled in a commercial claims database
between January 1, 2000-December 31, 2011 were included. Pharmacy claims within 7 days of diagnosis were searched for
antibiotic prescriptions. Antibiotic failure was defined as a dispensing of a different antibiotic class within 2-18 days after the
first prescription. We analyzed trends in antibiotic use and failure by class of antibiotic and year.
Results: We identified over 4 million children under 13 years with AOM. The proportion of antibiotic dispensing decreased
from 66.0% in 2005 to 51.9% in 2007, after which the instances of dispensing rebounded to pre-guideline levels. However,
levels began decreasing again in 2010 and the antibiotic use rate in 2011 was 57.6%. Cephalosporin prescriptions increased
by 41.5% over eleven years. Antibiotic failure decreased slightly, and macrolides had the lowest proportion of failures, while
all other classes had failure rates around 10%.
Conclusions: In recent years, antibiotic dispensing to treat AOM remains high. In addition, the use of broad-spectrum
antibiotics is increasing despite having a high rate of treatment failure. Overprescribing of antibiotics and use of non-
penicillin therapy for AOM treatment could lead to the development of antibiotic-resistant infections.
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Introduction
In children, acute otitis media (AOM) is one of the most
common infections for which antibiotics are prescribed.[1]_EN-
REF_1 The overuse of all types of antibiotics, as well as using
broad-spectrum antibiotics can lead to antibiotic-resistant bacte-
ria[2] and higher medical costs. Initiatives have been implemented
to increase the appropriate use of antibiotic prescribing among
physicians._ENREF_2 In 2004, the American Academy of
Pediatrics (AAP) and the American Academy of Family Physicians
(AAFP) released guidelines for management of AOM in children
,13 years that encouraged using antibiotics less frequently. These
guidelines include observation without treatment as an option for
certain age groups with non-severe or uncertain cases of AOM,
and the use of high-dose amoxicillin as first-line treatment for
severe cases or in younger age groups.[3] In 2013, these guidelines
were updated to include more stringent diagnosis criteria and
more specific definitions of categories for which antibiotics were
recommended.[4]
Because of the detrimental effects of over-prescribing antibiot-
ics, there has been a considerable effort to understand how the use
of these drugs has changed over time. Several studies in the late
1990s showed that overall antibiotic prescribing was decreasing
even prior to the AAP/AAFP guidelines;[5,6] however, some
found that use of broad-spectrum antibiotics was increasing.[7,8]
A study using national survey data from 2002 to 2006 found that
immediately after the initial guidelines were published there was a
non-significant decrease in encounters where antibiotics were
prescribed for AOM, and significant increases in the use of
amoxicillin as well as increases in the use of cephalosporins.[9] In
addition, treatment failure is an important outcome because
further prescribing of antibiotics, including broad-spectrum
antibiotics, is often the result. Several studies have included
clinical treatment failure as an endpoint, but these were
small[10,11] or focused solely on one type of antibiotic.[12,13]
One meta-analysis did report a higher risk of clinical failure for
macrolides compared to amoxicillin, however only included
studies through September 2008.[14] Relatively little is known
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about patterns of use of antibiotics to treat AOM and treatment
failure during the last five years.
To address these gaps in knowledge, we sought to examine
treatment patterns for AOM among a very large population of
children with commercial insurance using contemporary data. We
report proportions of dispensed antibiotic prescriptions to treat
AOM five years before and seven years after the initial 2004 AAP/
AAFP guidelines. We also examine trends in antibiotic failure over
time and compare the risk of failure by type of initial prescription.
Materials and Methods
Study Population
We analyzed data from the MarketScan Commercial Claims
and Encounters database (available for purchase from Truven
Health Analytics) between January 1, 2000-December 31, 2011.
The data capture patient-level data on inpatient, outpatient, and
prescription drug claims from approximately 150 large employers
and health plans that insure employees, early retirees and
dependents. This database includes 23 million children over ten
years. Drug information represents prescriptions that were
collected at a pharmacy.
Children aged 3 months to 12 years were included in the study
sample. Outpatient diagnoses are coded using International Classi-
fication of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM)
codes. We identified children with a diagnosis code for AOM as
either the primary or secondary diagnosis by the following ICD-9-
CM codes: 382.x, 384.2. These codes were chosen as the AAP/
AAFP guidelines were specific to these conditions. We also
compared our main cohort to children with a diagnosis of otitis
media with effusion (OME) (codes 381.0-381.4) – while the
guidelines were not focused on these conditions; we thought it
useful to also characterize prescribing trends for children with an
otitis media diagnosis where clinical guidelines suggest using
antibiotics less often. Children had to be enrolled for at least 90
days without an otitis media diagnoses to be considered a new
illness episode. We analyzed only the first new illness episode per
child, to make sure we did not include recurrent disease. We
further categorized children into age categories: ,2 years, 2–3
years, and 4+ years as prescribing patterns could vary by age.
Outcomes
For the initial otitis media diagnosis, we searched prescription
drug claims for all types of oral antibiotics. A drug claim was
considered linked to an outpatient diagnosis if it occurred within 7
days of the outpatient visit. We divided antibiotics into six
categories: amoxicillin, amoxicillin/clavulanate, unspecified pen-
icillins, macrolides, cephalosporins, and other antibiotics. If more
than one antibiotic was filled during the week following the
diagnosis, we counted each antibiotic in its respective class, but the
encounter only counted once as a visit for which antibiotics were
prescribed. Antibiotic failure was defined as children who filled a
prescription for an oral antibiotic, or were given injectable or
intravenous antibiotics (see Appendix S1 for codes) of a different
class within 2–18 days after the first prescription. We further
defined ‘‘early’’ and ‘‘late’’ failure to be 2–7 days and 8–18 days
respectively. As a secondary analysis, we limited our failure results
to children with no other diagnosis code of infection which could
likely result in additional antibiotic prescriptions (ICD-9-CM codes:
003–006, 033–034, 036, 038, 320, 322, 466.0, 481–486, 599.0).
Statistical Analysis
The proportion of children who were prescribed antibiotics was
compared to the proportion of children who were not prescribed
antibiotics. We evaluated overall antibiotic use and specific
antibiotics by year and by age category. To assess trends that
appeared approximately linear, we fit a linear regression to the
data and report the p-value for the trend. Differences in
proportions were assessed using a chi-square test. All analyses
were performed using SAS 9.2 (SAS Institute, Cary, North
Carolina).
Ethics Statement
This study was approved by the institutional review board of
University of North Carolina at Chapel Hill. As this study used de-
identified data as a secondary data analysis and was classified as
research involving no greater than minimal risk, the requirement
of obtaining informed consent was waived.
Results
There were 4,629,460 children aged 3 months – 12 years
identified with an AOM diagnosis, after dropping 101 children
who had a missing age. Overall, the mean age of the cohort was
3.8 years, while the median was 3.0 years. Children who were
given antibiotics were of similar age and gender as those who were
untreated (Table 1). There were differences in region in
prescribing patterns – the west region had higher rates of
prescribing antibiotics (66% vs 59%, 59%, and 60% for the
south, northeast, north central, respectively). In our secondary
cohort of children with an OME diagnosis, 42.2% received an
antibiotic. These children were slightly older, but were similar in
other demographic characteristics.
Over the 12 year period, 60.1% of children with AOM
diagnoses were dispensed antibiotics. The proportion of dispensing
decreased from 66.0% in 2005 to 51.9% in 2007, after which the
instances of antibiotic dispensing rebounded to pre-AAP/AAFP
guideline levels. However, levels began decreasing again in 2010
and antibiotic use in 2011 was 57.6%. Of all antibiotics dispensed,
54% were for amoxicillin. Use of amoxicillin decreased slightly –
from 57% to 53% between 2005–2008, but increased to pre-
guideline levels by 2011 (Figure 1A). This trend was seen in
children of all ages, although children 2 years and older had
slightly less antibiotic use.
Overall, non-amoxicillin containing antibiotics represented
30.6% of all first antibiotic dispensings. While macrolide use
remained constant at ,13% of dispensed antibiotic prescriptions
and amoxicillin/clavulanate declined slightly (p = 0.002), cephalo-
sporin use increased over time. Cephalosporin prescriptions
increased from a low of 12.3% in 2001, peaked in 2007, and
leveled out at 17.4% in 2011 (p = 0.0004). This was a 41.5%
increase over eleven years. (Figure 1B). Cefdinir accounted for
70.8% of all cephalosporin dispensings, and 96% of cephalosporin
dispensings were either second- or third-generation drugs.
Among children with AOM and with one initial prescription,
10.1% required an additional antibiotic within 2–18 days over the
12 year period (Table 2). Antibiotic failure decreased slightly over
time (p = 0.03) and only 9.6% required a second prescription in
2011 (Figure 2). Children less than 2 years of age had the highest
levels of failure (Figure 2A). Cephalosporins, amoxicillin/clavula-
nate and amoxicillin had similar failure proportions, while
macrolides had a lower failure rate (p,0.0001) (Table 2); however,
all antibiotic classes had a similar decline over time (Figure 2B).
When children with diagnosis codes for other infections were
excluded (N = 3,731), the failure proportions were similar (data not
shown). Among children requiring only one antibiotic for the
second dispensing, cephalosporins were the most common second
prescription (37.7%) and the majority of children who received
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amoxicillin, amoxicillin/clavulanate and macrolides as first agents
were switched to a cephalosporin (Table 3). For those started on a
cephalosporin, the majority were switched to amoxicillin/clavu-
lanate. Among children who experienced a treatment failure with
one initial therapy, 6.4% received multiple (2 or more) antibiotics
in subsequent dispensings.
Discussion
In this large, commercially-insured population of children
following the initial 2004 AAP/AAFP guidelines, we observed
an initial decrease in encounters with dispensed antibiotics to a low
of 51.9%. These estimates are lower than a study limited to two
years after the implementation of the guidelines, which estimated
that 84% of children were given prescriptions.[9] The discrepancy
may lie in the fact that Coco et al. used prescribed antibiotics while
our study used dispensed antibiotics. Two studies have reported
that approximately 18–25% of people do not fill antibiotic
prescriptions.[15,16] Furthermore, using dispensed antibiotics
captures the ‘‘observation + safety-net’’ option, where physicians
can write a prescription that the parent can fill if the child shows
no improvement after a specific length of time. Using dispensed
prescriptions as the outcome may give a more accurate picture of
the effect of the guidelines – as this observation period was one
way for physicians to decrease antibiotic use. One study estimated
in 2006, that surveyed physicians used the observation option in
15% of their patients.[17]
We observed that the decline in dispensing following the
implementation of the initial guidelines was not sustained.
Although most recent data suggests that dispensing is again on
the decline, antibiotic use has been near pre-guideline levels in
years after 2007. This could indicate that physicians may have
returned to past prescribing patterns. This agrees with a survey of
physicians that reported increasing discordancy with the guidelines
in choice of prescribed antibiotics over time.[17] Explanations for
this trend may be that the initial awareness of the guidelines may
have worn off, physicians have become overloaded with clinical
practice guidelines[18] or that physicians are generally more likely
Table 1. Characteristics of children aged 3 months to 12 years with a diagnosis of otitis media, 2000–2011.
Acute Otitis Media Otitis Media with Effusion
Antibiotics No Antibiotics Antibiotics No Antibiotics
N = 2,784,108 N = 1,845,352 N = 382,844 N = 523,618
N % N % N % N %
Mean age 3.8 3.52 3.9 3.53 4.1 3.6 4.4 3.5
(Std), years
Male sex 1,434,900 51.5 956,916 51.9 197,146 51.5 280,059 53.5
Region
Northeast 350,074 12.6 244,862 13.3 49,556 12.9 84,644 16.2
North central 737,316 26.5 492,061 26.7 92,455 24.2 131,932 25.2
South 1,157,846 41.6 810,230 43.9 173,537 45.3 226,192 43.2
West 504,608 18.1 261,696 14.2 62,990 16.5 71,919 13.7
Unknown 34,264 1.2 36,503 2.0 4,306 1.1 8.931 1.7
doi:10.1371/journal.pone.0081210.t001
Figure 1. Initial dispensed antibiotics to treat acute otitis media among children, by age (Panel A) and antibiotic type (Panel B).
doi:10.1371/journal.pone.0081210.g001
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to prescribe inappropriate antibiotics over time.[19] Physicians
might also have recognized that patients may have better
outcomes if given antibiotics. Recent randomized controlled trials
have shown that children given amoxicillin[20] or amoxicillin-
clavunate[21] had reduction in clinical failures as compared to
placebo. It is interesting to note that 42.2% of children with a
diagnosis of OME were treated. Clinical treatment guidelines for
OME recommend watchful waiting for 3 months for otherwise
healthy children, and include a specific recommendation to avoid
antimicrobial use.[22] This may be a population that could be
targeted for reduced antibiotic use. In fact, the 2013 update to the
AOM recommendations encourages physicians to employ stricter
diagnosis criteria to differentiate AOM and OME, and limit
subsequent prescribing for uncertain AOM diagnoses.
Additionally, we showed an increasing use in cephalosporins
used as initial treatment for AOM. Other studies have shown
similar increases for non-first-line antibiotics, particularly with the
antibiotic cefdinir.[7,9] Although cephalosporins may be used in
the case of penicillin allergy, it is estimated that the prevalence of
allergy is ,10%.[23] It is likely that increased use of cephalospo-
rins may be due to an easier dosing schedule or higher
tolerability[24] including fewer instances of diarrhea – a side
effect that is commonly seen with amoxicillin/clavulanate.
An encouraging finding is that treatment failures have
decreased, even with an increase in overall treatment since the
initial guidelines were published. Our estimates are similar to the
decreasing trend reported in a large, observational study of
children in Boston treated with high-dose amoxicillin, where the
relapse rate was 8.9% in 2004.[13] One explanation for
decreasing failure rates could be due to lower prevalence of
antibiotic-resistant strains of Streptococcus pneumoniae since the
introduction of the pneumococcal conjugate vaccine (PCV).
PCV-7 was introduced in 2001,[25] although supply issues limited
availability until 2004. In pre-vaccine years, Streptococcus pneumoniae
was a leading cause of AOM[26] and some strains have been
shown to be resistant to certain antibiotics. Since vaccine
introduction a small decline in AOM has been documented.[27]
Additionally, PCV-13 was introduced in 2010, and covers a
common strain that has been associated with antibiotic resistance
(serotype 19A).[28,29] The lower levels of treatment initiation and
failure in the last year of our study may be due to the impact of
PCV-13 on lowering the overall prevalence of otitis media caused
by S. pneumonia, as well as decreasing antibiotic resistant strains.
We also show that macrolides had a lower failure rate, while
cephalosporins, amoxicillin, and amoxicillin/clavulanate had
similar, higher rates of failure. Interestingly, macrolides had a
higher failure rate in the early failure window (3–7) days, but had a
lower failure rate in the late failure window. Possible explanations
for the lower overall rates of failure seen among macrolides could
be that physicians are using these drugs to treat to viral infections,
which would have resolved regardless of treatment, or that the
shorter course (5 days) results in higher compliance and better
Figure 2. Antibiotic failure among children with an acute otitis media diagnosis by age categories (Panel A) and initial antibiotic
type (Panel B).
doi:10.1371/journal.pone.0081210.g002
Table 2. Antibiotic failures* among children with an acute otitis media diagnosis and 1 initial dispensed antibiotic.
Overall Early** Late***
# Failures Failure proportion, % # Failures Failure proportion, % # Failures Failure proportion, %
All antibiotics 279,102 10.1 94,925 3.4 184,177 6.6
Cephalosporin 44,485 10.2 14,074 3.2 30,411 7.0
Macrolide 30,627 8.9 14,085 4.1 16,542 4.8
Amox./clav. 40,769 10.6 13,766 3.6 27,003 7.0
Amoxicillin 159,806 10.1 51,695 3.3 108,111 6.8
Other 3,312 11.5 1,263 4.4 2,049 7.1
*Failure is defined as having an additional, different class of antibiotic prescription within 2–18 days of the index prescription.
**Early failure = 2–7 days.
***Late failure = 8–18 days.
doi:10.1371/journal.pone.0081210.t002
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outcomes. Recent studies have reported contradictory results when
comparing failure rates between classes of antibiotics. One
population based, observational study reported similar positive
findings for macrolides as our study- azithromycin had a 12%
lower odds of failure as compared to amoxicillin._ENREF_22[30]
However, a meta-analysis suggested that macrolides had a higher
rate of clinical failure as compared to amoxicillin-containing
regimens (risk ratio 1.31 (95% CI: 1.07–1.60). The discrepancy
may lie with the varying definitions of treatment failure. We found
little consistency in the literature with regards to what events were
considered failures and the length of time that was considered for
the failure window. _ENREF_11 Therefore, it makes it difficult to
compare failure of different types of antibiotics across studies.
Though our results suggest a slightly lower failure rate among
macrolides, these data should be interpreted with caution when
considering a change in prescribing patterns, as we could not
incorporate antibiotic susceptibility testing of tympanocentesis
cultures. While the overall failure rate in our study decreased over
the 12 year period, possibly due to the introduction of PCV, it is
worrisome that the increasing use of cephalosporins as the initial
treatment could result in the use of more antibiotics overall.
There were several limitations to this study. First, we were
unable to distinguish the cause of the changing trends in treatment
patterns. It is possible that treatment patterns did actually change
in response to the guidelines. However, it is also possible that the
diagnosis of acute otitis media changed over time – if physicians
were diagnosing milder cases, this could create an appearance of a
decreased treatment effect. Therefore, it is possible that the
decrease in overall dispensing we showed between 2005 and 2007
was due to a change in diagnosing, as opposed to a change in
treatment patterns. Second, we did not have information on
weight in the dataset. This prohibited the assessment of whether a
certain antibiotic was classified as ‘‘high-dose,’’ particularly
amoxicillin containing antibiotics. Third, we did not take into
consideration if a child had either a past failure or an allergy to
penicillin, which could influence what type of initial antibiotic was
prescribed. Fourth, as the study population was limited to
commercially insured children, it may be difficult to generalize
to either noninsured or Medicaid populations. Further work
should be done to characterize the patterns of antibiotic use in
these populations. Fifth, our study was limited to dispensed
prescriptions where a claim was filed to the insurance company.
Antibiotics given as a free sample from a physician’s office or
through a pharmacy program giving free courses of generic
antibiotics would not be captured, and thus we may have
underestimated the actual amount of antibiotic use. However, it
has been estimated that only 5% of children received free samples
in 2004,[31] and therefore we believe that the misclassification in
our estimates would be minimal. Finally, our definition of
antibiotic failure does not capture whether the failure was truly
a clinical failure, a response to an adverse reaction to the first drug,
or due to subsequent infections. However, restricting the
population to those episodes where AOM was the only infectious
diagnosis code should help to more validly estimate treatment
failure. Our measure of failure does show the overall need for
multiple prescriptions regardless of the underlying mechanism.
Following the release of the initial AAP/AAFP guidelines, the
practice of antibiotic dispensing appears to have initially
decreased, followed by a rebound to pre-guideline levels. While
the most recent estimates indicate antibiotic treatment may again
be declining, overall use of antibiotics remains high. Additionally,
we document an increasing use of cephalosporins for first-line
treatment of AOM. This is discouraging in light of higher rates of
treatment failure observed with cephalosporins. Overprescribing
of antibiotics and use of non-amoxicillin therapy for AOM
treatment are worrisome as these deviations from treatment
guidelines could lead to the development and transmission of
antibiotic-resistant infections.
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